The National Malaria Control Division and Malaria Consortium conducted a phased seasonal malaria chemoprevention (SMC) implementation study in Karamoja region, Uganda, in 2021 and 2022. We evaluated the prevalence of molecular markers associated with sulphadoxine-pyrimethamine (SP), amodiaquine (AQ) and dihydroartemisinin-piperaquine (DP) resistance in five districts over the two years. Overall, SMC did not result in the selection for or any observable changes in resistance markers associated with SP, AQ and DP. As SMC expands in Karamoja region, ongoing surveillance for SP and AQ resistance markers will be needed.
This oral presentation was given at the Multilateral Initiative on Malaria (MIM) Society's 8th Pan-African Malaria Conference.
« Back to Publications